Evidence map›Paper›PMID 35706549›Full record

ArticleSouthern African journal of HIV medicine2022

Utilisation of cervical cancer screening among women living with HIV at Kenya's national referral hospital.

James M Kangethe, Aliza Monroe-Wise, Peter N Muiruri, James G Komu, Kenneth K Mutai, Mirriam M Nzivo, Jillian Pintye

Open access · goldAbstract read
In one paragraph

Article in Southern African journal of HIV medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

James M KangetheComprehensive Care Center, HIV Medicine, Kenyatta National Hospital, Nairobi, Kenya.ORCID https://orcid.org/0000-0001-5813-5360
Aliza Monroe-WiseDepartment of Global Health, University of Washington, Seattle, United States of America.ORCID https://orcid.org/0000-0002-8843-3462
Peter N MuiruriComprehensive Care Center, HIV Medicine, Kenyatta National Hospital, Nairobi, Kenya.ORCID https://orcid.org/0000-0003-4856-9805
James G KomuDepartment of Medical Laboratory Sciences, College of Health Sciences, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.ORCID https://orcid.org/0000-0001-5875-8285
Kenneth K MutaiComprehensive Care Center, HIV Medicine, Kenyatta National Hospital, Nairobi, Kenya.ORCID https://orcid.org/0000-0003-4887-4092
Mirriam M NzivoDepartment of Biological Sciences, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.ORCID https://orcid.org/0000-0001-5772-1579
Jillian PintyeDepartment of Global Health, International AIDS Research and Training Program, University of Washington, Seattle, United States of America.ORCID https://orcid.org/0000-0003-1255-7191
Jomo Kenyatta University of Agriculture and Technology · KEKenyatta National Hospital · KEUniversity of Washington · USUniversity of Nairobi · KE

Funding

Promoting Diversity, Equity, and Inclusivity in Research Training to Optimize HIV Prevention and TreatmentD43TW009580 · FIC · UNIVERSITY OF WASHINGTON · PI CAREY FARQUHAR, John Kinuthia · 2013 to 2026
$4.8M
FIC NIH HHS D43 TW009580Wellcome Trust
6 · The paper itself

Abstract

Background: In 2009, Kenyatta National Hospital (KNH) integrated cervical cancer screening within HIV care using visual inspection with acetic acid (VIA) and Pap smear cytology. Objectives: We evaluated utilisation of cervical cancer screening and human papillomavirus (HPV) vaccination among women living with HIV (WLHIV) receiving HIV care at KNH. Method: From November 2019 to February 2020, WLHIV aged ≥ 14 years were invited to participate in a survey following receipt of routine HIV services. We assessed awareness of cervical cancer, uptake of cervical cancer screening, uptake of the HPV vaccine, and barriers to utilisation of these services. In a subset of survey participants, focus group discussions (FGDs) were also conducted to identify screening barriers. Results: Overall, 305 WLHIV participated in the survey. Median age was 36 years (interquartile range [IQR]: 28-43), 41% were married, and 38% completed secondary education. Most (90%) had HIV RNA < 1000 copies/mL. Awareness of cervical cancer was high (84%), although only 45% of WLHIV had screened for cervical cancer at the referral hospital and only 13% knew how to prevent high-risk HPV. No participants had received an HPV vaccination. Older age, higher education, and knowledge of the HPV vaccine were associated with higher likelihood of cervical cancer screening ( Conclusion: Despite integration with HIV services, the utilisation of cervical cancer screening was low among WLHIV and implementation barriers contributed to low utilisation.

Indexed as

cervical cancerintegrated cervical cancer screeningKenyautilisationwomen living with HIV

Identifiers

PMID35706549
PMCPMC9082290
OpenAlexW4224753836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.